Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Podcasts

Dr Jason Levy
Podcast
RFA in Radiation-Naïve Patients for Palliation of Osseous Metastases: A Conversation With Jason Levy, MD, FSIR
01/18/2022
"Best CIO Abstract" Winner Dr Jason Levy discusses an OPuS-One subanalysis that examined subjects who did not receive radiation therapy at the site of RFA before or after RFA treatment.
"Best CIO Abstract" Winner Dr Jason Levy discusses an OPuS-One subanalysis that examined subjects who did not receive radiation therapy at the site of RFA before or after RFA treatment.
"Best CIO Abstract" Winner Dr...
01/18/2022
IO Learning

Advertisement

Dr Erik van der Heijden
Podcast
Recent Advancements in the Diagnostic Accuracy of Navigation Bronchoscopy: A Conversation With Erik van der Heijden, MD
12/22/2021
Dr. Erik van der Heijden, Pulmonologist and Associate Professor of Interventional Pulmonary Diseases at Radboud UMC in the Netherlands, joins us to discuss recent advancements in the accuracy and safety of lung biopsy procedures using the...
Dr. Erik van der Heijden, Pulmonologist and Associate Professor of Interventional Pulmonary Diseases at Radboud UMC in the Netherlands, joins us to discuss recent advancements in the accuracy and safety of lung biopsy procedures using the...
Dr. Erik van der Heijden,...
12/22/2021
IO Learning
Dr Tomkovich
Podcasts
Interview With Dr Kenneth Tomkovich: ICE3 Trial 3-Year Interim Results
10/20/2021
The ICE3 trial was designed to evaluate the safety and efficacy of breast cryoablation in women older than 60 years with low-risk early-stage breast cancers. Dr Kenneth Tomkovich, co-principal investigator of ICE3, joined us to discuss the...
The ICE3 trial was designed to evaluate the safety and efficacy of breast cryoablation in women older than 60 years with low-risk early-stage breast cancers. Dr Kenneth Tomkovich, co-principal investigator of ICE3, joined us to discuss the...
The ICE3 trial was designed to...
10/20/2021
IO Learning
Dr Ripal Gandhi
Podcast
CIO 2021 Preview With Dr Ripal Gandhi
09/22/2021
CIO 2021 is coming up soon in Miami, Florida on October 22nd-24th. Join one of our CIO course directors, Dr Ripal Gandhi, for a preview.
CIO 2021 is coming up soon in Miami, Florida on October 22nd-24th. Join one of our CIO course directors, Dr Ripal Gandhi, for a preview.
CIO 2021 is coming up soon in...
09/22/2021
IO Learning

Advertisement

Steven Yevich, MD
Podcast
IO Learning Welcomes Editor-in-Chief, Steven Yevich, MD, MPH
09/10/2021
Interview with our newly appointed Editor-in-Chief, Dr Steven Yevich, Associate Professor in the Department of Interventional Radiology and Division of Diagnostic Imaging at the University of Texas MD Anderson Cancer Center in Houston, Texas.
Interview with our newly appointed Editor-in-Chief, Dr Steven Yevich, Associate Professor in the Department of Interventional Radiology and Division of Diagnostic Imaging at the University of Texas MD Anderson Cancer Center in Houston, Texas.
Interview with our newly...
09/10/2021
IO Learning
Dr Barbara Hamilton
Podcast
IOL Radio Podcast: Dr Barbara Hamilton, Author of "Save Lives, Enjoy Your Own"
06/10/2021
Barbara Hamilton, MD, joins us to discuss her recent book, "Save Lives, Enjoy Your Own," which encourages women to thrive in surgically oriented and traditionally male-dominated fields.
Barbara Hamilton, MD, joins us to discuss her recent book, "Save Lives, Enjoy Your Own," which encourages women to thrive in surgically oriented and traditionally male-dominated fields.
Barbara Hamilton, MD, joins us...
06/10/2021
IO Learning
TARGET
Podcast and Video
TARGET Study Confirms the Significance of Tumor Absorbed Dose of Tumor Response and Overall Survival
06/05/2021
TARGET is a global real-world study set across eight countries that confirms TheraSphere as safe and effective treatment for HCC, demonstrating reproducible clinical outcomes across a broad patient population. Professor Marnix Lam and Dr....
TARGET is a global real-world study set across eight countries that confirms TheraSphere as safe and effective treatment for HCC, demonstrating reproducible clinical outcomes across a broad patient population. Professor Marnix Lam and Dr....
TARGET is a global real-world...
06/05/2021
IO Learning

Advertisement

Dr Jason Levy
Podcasts
Twelve-Month Outcomes From the OPuS-One Study: A Conversation With Dr Jason Levy
05/25/2021
This episode of IOL Radio features Dr Jason Levy, lead investigator of the OPuS One trial, which studied the quality of life outcomes from a global, prospective, non-randomized, multicenter study of RFA using Medtronic’s OsteoCool system for...
This episode of IOL Radio features Dr Jason Levy, lead investigator of the OPuS One trial, which studied the quality of life outcomes from a global, prospective, non-randomized, multicenter study of RFA using Medtronic’s OsteoCool system for...
This episode of IOL Radio...
05/25/2021
IO Learning
Dr Joseph J. Busch and Kathy Busch
Podcasts
Integrating the TULSA System Into a Dedicated Prostate Cancer Treatment Facility
02/23/2021
Our guests today are from the Busch Center, a clinic in Alpharetta, Georgia that is dedicated to the screening, diagnosis, and treatment of prostate cancer. Dr Joseph J. Busch, Junior, is the clinic’s Oncological Radiologist, and has over 40...
Our guests today are from the Busch Center, a clinic in Alpharetta, Georgia that is dedicated to the screening, diagnosis, and treatment of prostate cancer. Dr Joseph J. Busch, Junior, is the clinic’s Oncological Radiologist, and has over 40...
Our guests today are from the...
02/23/2021
IO Learning
LEGACY
Podcasts
The LEGACY Study Confirms TheraSphere™ as a Neoadjuvant or Standalone Therapy in Treating HCC
12/10/2020
In this episode of IOL Radio, we discuss the results of the LEGACY Study, a robust multicenter study confirming Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating hepatocellular carcinoma.
In this episode of IOL Radio, we discuss the results of the LEGACY Study, a robust multicenter study confirming Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating hepatocellular carcinoma.
In this episode of IOL Radio, we...
12/10/2020
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
Allison Casey
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management
News
Radiation Therapy May Be Potential Heart Failure Treatment
11/28/2023

Julia Evangelou Strait

Julia Evangelou Strait
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose...
11/28/2023
Cath Lab Digest
News
Canon Medical Introduces Alphenix Sky 12 HD Interventional System
09/12/2023
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) —...
09/12/2023
IO Learning

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use